Pei-Yi Chu Selected Research

Ulcer

1/2013	Protective effect of 3,4-methylenedioxyphenol (sesamol) on stress-related mucosal disease in rats.
7/2009	Effect of sesame oil on acidified ethanol-induced gastric mucosal injury in rats.
10/2008	Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pei-Yi Chu Research Topics

Disease

98	Neoplasms (Cancer) 05/2024 - 02/2011
37	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2011
23	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2008
15	Triple Negative Breast Neoplasms 01/2023 - 04/2012
14	Carcinogenesis 01/2024 - 07/2011
13	Hepatocellular Carcinoma (Hepatoma) 05/2023 - 01/2010
9	Inflammation (Inflammations) 07/2020 - 08/2012
6	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 04/2021
6	Squamous Cell Carcinoma of Head and Neck 01/2021 - 02/2012
5	Stomach Neoplasms (Stomach Cancer) 08/2022 - 08/2011
4	Colonic Neoplasms (Colon Cancer) 05/2024 - 02/2017
4	Carcinoma (Carcinomatosis) 05/2023 - 10/2011
4	Primitive Neuroectodermal Tumors (PNET) 11/2022 - 11/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 08/2012
4	Lymphatic Metastasis 01/2021 - 02/2012
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2013
3	Wounds and Injuries (Trauma) 01/2022 - 03/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2016
3	Osteoarthritis 03/2016 - 01/2015
3	Acute Kidney Injury (Acute Renal Failure) 01/2015 - 06/2011
3	Ulcer 01/2013 - 10/2008
2	Body Weight (Weight, Body) 02/2024 - 06/2011
2	Adenocarcinoma of Lung 01/2024 - 05/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 07/2020
2	Liver Neoplasms (Liver Cancer) 12/2020 - 10/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 07/2019
2	Adenocarcinoma 11/2018 - 08/2012

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2010
25	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2012
9	Estrogen ReceptorsIBA 01/2023 - 02/2011
9	Phosphotransferases (Kinase)IBA 01/2022 - 02/2012
9	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 01/2013
7	EnzymesIBA 05/2024 - 10/2011
7	Sesame Oil (Oil, Sesame)IBA 03/2016 - 07/2009
6	Messenger RNA (mRNA)IBA 01/2023 - 07/2020
6	sesamolIBA 01/2015 - 03/2006
5	Therapeutic UsesIBA 04/2024 - 05/2012
5	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2022 - 01/2014
5	CateninsIBA 02/2022 - 01/2018
5	LigandsIBA 02/2022 - 04/2011
5	Indicators and Reagents (Reagents)IBA 04/2021 - 08/2012
5	ErbB Receptors (EGF Receptor)IBA 02/2016 - 04/2011
4	CalciumIBA 04/2024 - 10/2020
4	LipidsIBA 02/2024 - 04/2011
4	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2016
4	Hormones (Hormone)IBA 01/2024 - 04/2012
4	Adenosine Triphosphate (ATP)IBA 01/2023 - 12/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2011
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 09/2020 - 11/2013
4	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2013
4	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2019 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 04/2015 - 01/2013
4	CytokinesIBA 04/2015 - 12/2009
4	NitritesIBA 01/2015 - 10/2008
3	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2022
3	mitochondrial calcium uniporterIBA 04/2024 - 10/2020
3	regorafenibIBA 01/2023 - 11/2014
3	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2019
3	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2022 - 09/2014
3	IronIBA 11/2021 - 05/2012
3	Hyaluronic Acid (Hyaluronan)IBA 08/2021 - 08/2018
3	Arecoline (Arecolin)IBA 01/2021 - 04/2011
3	InterleukinsIBA 09/2020 - 01/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 01/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 11/2015
3	Phosphopyruvate Hydratase (Enolase)IBA 10/2015 - 10/2011
3	LipopolysaccharidesIBA 01/2015 - 12/2009
3	Hydroxyl RadicalIBA 06/2011 - 03/2006
3	Superoxides (Superoxide)IBA 06/2011 - 03/2006
2	CatalaseIBA 01/2024 - 03/2006
2	Methionine (L-Methionine)FDA Link 05/2023 - 05/2021
2	human ERBB2 proteinIBA 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 10/2020
2	PhosphoenolpyruvateIBA 01/2023 - 11/2017
2	Gemcitabine FDA Link 01/2023 - 12/2018
2	TensinsIBA 11/2022 - 11/2017
2	Cyclin D1IBA 02/2022 - 01/2013
2	Aurora Kinase AIBA 02/2022 - 01/2022
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 08/2021 - 08/2018
2	SolutionsIBA 08/2021 - 07/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021 - 08/2018
2	P-SelectinIBA 08/2021 - 07/2019
2	fucoidanIBA 08/2021 - 07/2019
2	Phenobarbital (Luminal)FDA Link 01/2021 - 07/2009
2	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 01/2021 - 04/2020
2	CarcinogensIBA 01/2021 - 04/2015
2	Vascular Endothelial Growth Factor CIBA 01/2021 - 08/2019
2	KynurenineIBA 01/2021 - 04/2020
2	OxidesIBA 01/2020 - 04/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2019 - 08/2012
2	Leucine (L-Leucine)FDA Link 01/2019 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 08/2018 - 01/2017

Therapy/Procedure

32	Therapeutics 05/2024 - 01/2014
7	Precision Medicine 04/2024 - 01/2020
6	Drug Therapy (Chemotherapy) 05/2024 - 01/2016
4	Immunotherapy 01/2023 - 07/2017
2	Neoadjuvant Therapy 01/2020 - 01/2016